Glucose control during acute myocardial infarction

Internal Medicine Journal

Volumn 38, Issue 5, 2008, Pages 345-348

  Cheung, N W ^a,b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Glucose; Hyperglycaemia; Insulin; Myocardial infarction; Therapeutics

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; POTASSIUM;

ACUTE HEART INFARCTION; DIABETES MELLITUS; GLUCOSE INFUSION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; INSULIN INFUSION; INTENSIVE CARE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

BLOOD GLUCOSE; HUMANS; HYPERGLYCEMIA; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 42049091067     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01640.x     Document Type: Review

References (20)

1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000 355 : 773 8.
2. Wong V, Ross DL, Park K, Boyages S, Cheung NW. Hyperglycemia following acute myocardial infarction is a predictor of poor cardiac outcomes in the reperfusion era. Diabetes Res Clin Pract 2004 64 : 85 91.
3. Wong V, Cheung NW, Boyages SC. Glycometabolic status and acute myocardial infarction: has the time come for glucose-insulin-(potassium) therapy? Intern Med J 2003 33 : 443 9.
4. The CREATE-ECLA Trial Group Investigators. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 2005 293 : 437 6.
5. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A et al. Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol 1995 26 : 57 65.
6. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997 314 : 1512 15.
7. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2); effects on mortality and morbidity. Eur Heart J 2005 26 : 650 61.
8. Cheung NW, Wong V, McLean M. The Hyperglycemia: Intensive Insulin Infusion In Infarction (HI-5) Study - a randomised controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care 2006 29 : 765 70.
9. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001 345 : 1359 67.
10. Van den Berghe G, Wouters P, Bouillon R, Weekers F, Verwaest C, Schetz M et al. Outcome of intensive insulin therapy in the critically ill: Insulin dose versus glycaemic control. Crit Care Med 2003 31 : 359 66.
11. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 : 449 61.
12. Shizukuda Y, Reyland ME, Buttrick PM. Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol Heart Circ Physiol 2002 282 : H1625 34.
13. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006 295 : 1681 7.
14. Davi G, Catalano I, Averna M, Notarbartolo A, Strano A, Ciabattoni G et al. Thromboxane biosynthesis and platelet function in type II diabetes. N Engl J Med 1990 322 : 1769 74.
15. Pandolfi A, Giaccari A, Cilli C, Alberta MM, Morviducci L, De Filippis FA et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol 2001 38 : 71 6.
16. Marfella R, Siniscalchi M, Esposito K, Sellito A, De Fanis U, Romano C et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 2003 26 : 3129 35.
17. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndromes: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol 2006 109 : 248 56.
18. Ray KK, Cannon CP, Morrow DA, Kirtane AJ, Buros J, Rifai N et al. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 2007 28 : 806 13.
19. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, van den Berghe G. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003 88 : 1082 8.
20. Wong V, McLean M, Boyages S, Cheung NW. CRP levels following acute myocardial infarction. Effect of insulin infusion and tight glycemic control. Diabetes Care 2004 27 : 2971 3.